Why Corteva Stock Is Rocketing Higher Today

Corteva (CTVA) jumped 12.99% after JPMorgan (JPM) upgraded the stock to overweight with a $19 price target. That target implies 53.3% upside from the prior close of $12.39.

The upgrade follows Corteva's October spinoff of its advanced seed and genetics business. JPMorgan's view, as reported, is that the company is now undervalued in its post-spinoff form.

The bull case leans on the crop protection segment. According to the source, that business added more than $1 billion in sales and expanded margins by 250 basis points between 2020 and 2025. Those figures give the upgrade a concrete operating record to point to, rather than a purely valuation-driven argument.

Interpretation: a double-digit single-session move on one analyst call suggests the market had been underpricing the post-spinoff structure, or that positioning was light heading into the upgrade. The size of the gap between the $19 target and the pre-upgrade price shows how much room JPMorgan sees for a rerating, though a 12.99% pop may already pull forward part of that move.